A Cure in Our Lifetime Inc

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2011

Legal Domicile

Phone

9142164100

Tax Period

2025-01-01 to 2025-12-31

A Cure in Our Lifetime Inc, founded in 2011, is a small nonprofit in the Diseases & Disorders sector that reported $501K in total revenue in fiscal year 2025. Revenue surged 23% from the prior year, signaling strong growth momentum.

Mission

A Cure in Our Lifetime: Our mission is to fund innovative breast cancer research, provide resources for those who have breast cancer, and promote breast health through education and outreach. We are an all volunteer organization. Since 1998, A Cure In Our Lifetime nationally has raised over $3,500,000 in the fight against breast cancer.

Program Service Accomplishments

Program 1

Expenses: $481,200

Since 1998, A Cure In Our Lifetime nationally has raised over $3,500,000 in the fight against breast cancer. The mission is to fund innovative breast cancer research, provide resources for those who...

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $38,949

Program Service Revenue $0

Investment Income $11

Other Revenue $461,910

TOTAL REVENUE $500,870

Expense Breakdown

Grants Paid $481,000

Salaries & Benefits $0

Fundraising Expenses $13,907

Program Expenses $481,200

Other Expenses $29,627

TOTAL EXPENSES $510,627

Year-over-Year Comparison

	2025	2024	Change
Revenue	$500,870	$408,579	+0.2%
Expenses	$510,627	$415,346	+0.2%
Net Income	$-9,757	$-6,767	+0.4%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Role	Reportable Comp	Other Comp	Total
Marge Orell	Director	Director	$0	$0	$0
Mindy Unger	Director	Director	$0	$0	$0
Laura Friedman	President	Officer	$0	$0	$0
Karen Taub	Vice President	Officer	$0	$0	$0
Jennifer Fink	Secretary	Officer	$0	$0	$0
Ellen Horing	Treasurer	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$500,870	$510,627	$108,327	$-9,757
2024	No data	No data	No data	No data
2023	$352,660	$510,826	$92,571	$-158,166
2022	$379,453	$208,440	$231,539	$171,013
2021	$207,899	$263,499	$60,527	$-55,600
2020	$215,951	$202,314	$116,127	$13,637
2019	$347,121	$320,888	$102,490	$26,233
2018	$379,415	$358,507	$76,257	$20,908